AMRX Amneal Pharmaceuticals Earnings and EPS analysis

EPS in 2026 (TTM): $0.39

Last Report Period Date: Mar 31, 2026

Currently, AMRX's current EPS stands at $0.39, according to the most recent financial reports. For the year 2025, AMRX reported a per-share earnings of $0.23, which marks an increase compared to the EPS of -$0.38 recorded in 2024. AMRX recorded an EPS of $0.2 for the quarterly period ending on Mar 31, 2026.

In 2025, Amneal Pharmaceuticals's EPS was $0.23, an increase of 160.5% from -$0.38 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0.2, reflecting a 400% increase compared to the same quarter a year earlier. For the twelve months ending March 2026, the EPS is $0.39. For the year 2024, the yearly earnings per share was -$0.38, marking an increase of 20.8% compared to 2023.

Over the past 12 months, Amneal Pharmaceuticals has recorded an earnings per share growth of 400% (YoY, quarterly). During the last five years, the company had an average annual EPS growth of -18%.